Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $48.00 at UBS Group - MarketBeat
Google News – Pharmaceuticals External News
BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It? - Yahoo Finance
Google News – Pharmaceuticals External News
SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
Google News – FDA (biotech/pharma) External News
FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease - medcitynews.com
Google News – FDA (biotech/pharma) External News
FDA Nominee Heidi Overton Has No Pharma Ties and a Policy Agenda That Could Rattle The Industry - finance.biggo.com
Google News – Pharmaceuticals External News
How Pharma Will Navigate the NDC-12 Transition - Pharmaceutical Commerce
Google News – Pharmaceuticals External News
Tarsus Pharmaceuticals stock hits all-time high at 85.29 USD - Investing.com
Google News – Pharmaceuticals External News
A new Jazz Pharmaceuticals Quality Improvement Grants opportunity is Now Accepting Applications! - Conquer Cancer - Oncodaily
Google News – Pharmaceuticals External News
Tarsus Pharmaceuticals stock hits all-time high at 85.29 USD By Investing.com - Investing.com Canada
Google News – Pharmaceuticals External News
FDA Approves Zanvastro | PharmExec - Pharmaceutical Executive
Google News – Clinical Trials External News
AI is helping get new medicines to patients sooner. Here's how - usatoday.com
Google News – FDA (biotech/pharma) External News
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging. - Barron's
Google News – Biopharma External News
Trailing rivals, AbbVie scores win with dual-acting myeloma drug - BioPharma Dive
Google News – Pharmaceuticals External News